Literature DB >> 23443917

Indicator measures er/pr and her2 testing among women with invasive breast cancer.

C Sandoval1, R Rahal, T Forte, J Klein-Geltink, D He, H Bryant.   

Abstract

Entities:  

Year:  2013        PMID： 23443917      PMCID： PMC3557332          DOI： 10.3747/co.20.1290

Source DB:  PubMed          Journal:  Curr Oncol        ISSN： 1198-0052            Impact factor:   3.677


× No keyword cloud information.
  2 in total

Review 1.  HER2 testing in breast cancer: NCCN Task Force report and recommendations.

Authors:  Robert W Carlson; Susan J Moench; M Elizabeth H Hammond; Edith A Perez; Harold J Burstein; D Craig Allred; Charles L Vogel; Lori J Goldstein; George Somlo; William J Gradishar; Clifford A Hudis; Mohammad Jahanzeb; Azadeh Stark; Antonio C Wolff; Michael F Press; Eric P Winer; Soonmyung Paik; Britt-Marie Ljung
Journal:  J Natl Compr Canc Netw       Date:  2006-07       Impact factor: 11.908

Review 2.  NCCN Task Force Report: Estrogen Receptor and Progesterone Receptor Testing in Breast Cancer by Immunohistochemistry.

Authors:  D Craig Allred; Robert W Carlson; Donald A Berry; Harold J Burstein; Stephen B Edge; Lori J Goldstein; Allen Gown; M Elizabeth Hammond; James Dirk Iglehart; Susan Moench; Lori J Pierce; Peter Ravdin; Stuart J Schnitt; Antonio C Wolff
Journal:  J Natl Compr Canc Netw       Date:  2009-09       Impact factor: 11.908
  2 in total
  6 in total

1.  Discovery and Development of the Aryl O-Sulfamate Pharmacophore for Oncology and Women's Health.

Authors:  Mark P Thomas; Barry V L Potter
Journal:  J Med Chem       Date:  2015-06-12       Impact factor: 7.446

Review 2.  Treatment Considerations for the Management of Patients With Hormone Receptor-Positive Metastatic Breast Cancer.

Authors:  Constance Visovsky
Journal:  J Adv Pract Oncol       Date:  2014 Sep-Oct

3.  Visceral Crisis Means Short Survival Among Patients With Luminal A Metastatic Breast Cancer: A Retrospective Cohort Study.

Authors:  Yassir Sbitti; Khaoula Slimani; Adil Debbagh; Anouar Mokhlis; Habiba Kadiri; Abdelilah Laraqui; Hassan Errihani; Mohamed Ichou
Journal:  World J Oncol       Date:  2017-08-27

Review 4.  Improving accuracy of breast cancer biomarker testing in India.

Authors:  Tanuja Shet
Journal:  Indian J Med Res       Date:  2017-10       Impact factor: 2.375

5.  Serum atrial natriuretic peptide: a suspected biomarker of breast cancer.

Authors:  Maha E Houssen; Hayam F Ghazy; Kamel Farag; Mona Abo Bakr El-Hussiny; Mohamed A El Ghaffar; Sahar Alsayed Mohamed Alsayed; Omar Farouk
Journal:  Contemp Oncol (Pozn)       Date:  2017-03-22

6.  Defining the optimal sequence for the systemic treatment of metastatic breast cancer.

Authors:  J A Mestres; A B iMolins; L C Martínez; J I C López-Muñiz; E C Gil; A de Juan Ferré; S Del Barco Berrón; Y F Pérez; J G Mata; A G Palomo; J G Gregori; P G Pardo; J J I Mañas; A L Hernández; E M de Dueñas; N M Jáñez; S M Murillo; J S Bofill; P Z Auñón; P Sanchez-Rovira
Journal:  Clin Transl Oncol       Date:  2016-06-17       Impact factor: 3.405
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.